Vicore Pharma Holding AB (publ) (VICO) — Cash Flow Reinvestment Rate
Latest as of March 2024:
3.03x
Vicore Pharma Holding AB (publ) (VICO) has a Cash Flow Reinvestment Rate of 3.03x as of March 2024, reinvesting Skr70.00 Million (capex Skr0.00 plus investments Skr70.00 Million) from operating cash flow of Skr23.08 Million. See VICO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
3.03x
(Capex + Investments) / Operating CF
Total Reinvested
Skr70.00 Million
Capex + Investments
Operating Cash Flow
Skr23.08 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Vicore Pharma Holding AB (publ) (None–None)
Year-by-year capital reinvestment analysis for Vicore Pharma Holding AB (publ). See how financially flexible is Vicore Pharma Holding AB (publ) to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow